LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

Clinical trial NCT05900986 · COMPLETED

Trial details

NCT number: NCT05900986
Sponsor: Integro Theranostics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer DCIS Invasive Duct Carcinoma of Breast

Start date: 2023-07-14
Primary completion: 2025-10-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.